Prospective, Randomized Trial of Belatacept Switch in Renal Transplant Recipients With Delayed Graft Function

Trial Profile

Prospective, Randomized Trial of Belatacept Switch in Renal Transplant Recipients With Delayed Graft Function

Recruiting
Phase of Trial: Phase 0

Latest Information Update: 01 Feb 2017

At a glance

  • Drugs Belatacept (Primary) ; Everolimus
  • Indications Delayed graft function
  • Focus Therapeutic Use
  • Most Recent Events

    • 23 Jan 2017 Planned End Date changed from 1 Dec 2016 to 1 Dec 2017.
    • 23 Jan 2017 Planned primary completion date changed from 1 Sep 2016 to 1 Dec 2017.
    • 02 Jul 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top